| but first let's shift our attention over | 4.56 | Jump to 4.4 |  |  | 
              
                
                  | children under five a big development | 2.881 | Jump to 13.599 |  |  | 
              
                
                  | two and three doses in our younger age | 4.32 | Jump to 70.56 |  |  | 
              
                
                  | rather that the a two dose vaccine was | 5.2 | Jump to 77.2 |  |  | 
              
                
                  | not as effective for that under five | 4.239 | Jump to 79.92 |  |  | 
              
                
                  | group and so they're looking at a third | 4.399 | Jump to 82.4 |  |  | 
              
                
                  | either way if they do need three doses | 4.48 | Jump to 87.52 |  |  | 
              
                
                  | the process of the two doses for the | 4.879 | Jump to 98.24 |  |  | 
              
                
                  | the last two years we've become | 3.28 | Jump to 112.24 |  |  | 
              
                
                  | visor being the only one that is at this | 4.32 | Jump to 159.68 |  |  | 
              
                
                  | that 5 to 11 cohort of of a patient | 6.321 | Jump to 166.239 |  |  | 
              
                
                  | stagnant about 20 percent of the | 4.959 | Jump to 177.2 |  |  | 
              
                
                  | five to eleven so that shows that there | 4.8 | Jump to 182.159 |  |  | 
              
                
                  | your point yes there are five and under | 3.841 | Jump to 186.959 |  |  |